 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 02/19/2021 |
$2.49 |
$2.50 |
$2.32 |
$2.41 |
3.53M | | 02/22/2021 |
$2.36 |
$2.43 |
$2.23 |
$2.23 |
3.25M | | 02/23/2021 |
$2.14 |
$2.17 |
$1.88 |
$2.10 |
4.97M | | 02/24/2021 |
$2.15 |
$2.32 |
$2.15 |
$2.20 |
2.78M | | 02/25/2021 |
$2.15 |
$2.84 |
$2.13 |
$2.49 |
17.45M |
|
|
| Abeona Therapeutics is a biopharmaceutical company developing gene and cell therapies for rare genetic diseases. Co.'s clinical programs consist of: EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B. Co. has other AAV-based gene therapies in developmental stages designed to treat the CLN1 and CLN3 forms of Batten Disease, cystic fibrosis and retinal diseases. Co. is also developing AAV-based gene therapies through its AIM™ capsid platform and internal AAV vector research programs. | |
|
Abeona Therapeutics (ABEO) has the following price history information. Looking back at ABEO historical stock prices for the last five trading days, on February 19, 2021, ABEO opened at $2.49, traded as high as $2.50 and as low as $2.32, and closed at $2.41. Trading volume was a total of 3.53M shares. On February 22, 2021, ABEO opened at $2.36, traded as high as $2.43 and as low as $2.23, and closed at $2.23. Trading volume was a total of 3.25M shares. On February 23, 2021, ABEO opened at $2.14, traded as high as $2.17 and as low as $1.88, and closed at $2.10. Trading volume was a total of 4.97M shares. On February 24, 2021, ABEO opened at $2.15, traded as high as $2.32 and as low as $2.15, and closed at $2.20. Trading volume was a total of 2.78M shares. On February 25, 2021, ABEO opened at $2.15, traded as high as $2.84 and as low as $2.13, and closed at $2.49. Trading volume was a total of 17.45M shares.
ABEO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Abeona Therapeutics shares, starting with a $10,000 purchase of ABEO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/28/2011 |
|
| End date: |
02/25/2021 |
|
| Start price/share: |
$2.20 |
|
| End price/share: |
$2.49 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
13.18% |
|
| Average Annual Total Return: |
1.25% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$11,322.71 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 02/19/2021 | $2.41 | | 02/22/2021 | $2.23 | | 02/23/2021 | $2.10 | | 02/24/2021 | $2.20 | | 02/25/2021 | $2.49 |
|
|
